Pharmacist-led multidisciplinary approach in preventing strokes in people with atrial fibrillation
Poster code: HPS-094
By: ANTONIOU, Sotiris (Barts Health NHS Trust, London, , United Kingdom)
Co-author(s):
Mr Mital Patel, Pharmacist (Barts Health NHS Trust, London, United Kingdom)
Ms Shabana Ali (NHS Redbridge Clinical Commissioning Group, London, United Kingdom)
Mr John Robson (Queen Mary University of London, Clinical Effectiveness Group, London, United Kingdom)
Mr Richard Clements (NHS North East London Clinical Commissioning Group, London, United Kingdom)
Mrs Angela Theodoulou, Haematology (Barts Health NHS Trust, London, United Kingdom)
Mr Paul Wright, Pharmacy (Barts Health NHS Trust, London, United Kingdom)
Mr Matt Kearney (UCLPartners, London, United Kingdom)
Mr Riyaz Patel, Cardiology (Barts Health NHS Trust, London, United Kingdom)
Mr Afzal Sohaib, Cardiology (Barking, Havering and Redbridge Hospitals NHS trust, London, United Kingdom)
Mr Sotiris Antoniou, Pharmacy (Barts Health NHS Trust, London, United Kingdom)
Background: Targets set by Public Health England (PHE) state that 90% of patients with atrial fibrillation (AF) are expected to receive anticoagulation by 2029. In 2019/2020, across three London boroughs serving a population of 770,000, the percentage of AF patients at high risk of stroke (CHA₂DS₂VASc≥2) anticoagulated was below the target set by
Our members Pediatric formulations focus group